Darren Jolliffe
Overview
Explore the profile of Darren Jolliffe including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
68
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rockstroh J, Asmuth D, Pantaleo G, Clotet B, Podzamczer D, van Lunzen J, et al.
PLoS One
. 2019 Jan;
14(1):e0210965.
PMID: 30699178
Background: Vacc-4x, a therapeutic HIV vaccine candidate has previously induced a significant reduction in viral load (VL) set-point compared to placebo upon interruption of combination anti-retroviral therapy (ART) (2007/1 study)....
2.
Huang Y, Zhang L, Jolliffe D, Sanchez B, Stjernholm G, Jelmert O, et al.
AIDS Res Hum Retroviruses
. 2018 Jan;
34(3):307-313.
PMID: 29297230
Therapeutic vaccination has the potential to contribute to functional HIV cure strategies. However, to show functional HIV cure, study participants must be taken off combination antiretroviral therapy (cART). The availability...
3.
Huang Y, Zhang L, Jolliffe D, Hovden A, Okvist M, Pantaleo G, et al.
Vaccine
. 2016 Jan;
34(10):1282-8.
PMID: 26826543
Background: In a randomized, double-blind, placebo-controlled phase 2 clinical trial of Vacc-4x, a peptide-based therapeutic HIV-1 p24(Gag) vaccine candidate, 135 HIV-infected participants (vaccine:placebo=92:43) received a series of six immunizations while...
4.
Pollard R, Rockstroh J, Pantaleo G, Asmuth D, Peters B, Lazzarin A, et al.
Lancet Infect Dis
. 2014 Feb;
14(4):291-300.
PMID: 24525316
Background: Present combination antiretroviral therapy (cART) alone does not cure HIV infection and requires lifelong drug treatment. The potential role of HIV therapeutic vaccines as part of an HIV cure...